Abstract
Introduction
Obesity has a derogatory effect on female reproductive health. Obesity contributes to difficulty in natural conception, increased risk of pregnancy-associated complications, miscarriages, congenital anomalies, and also the long-term negative impact on both mother and the child.
Objectives
Our study aimed to analyze and assess the reproductive health-associated outcomes of females who underwent bariatric surgery.
Methods
We performed a retrospective analysis from a prospectively collected database from June 2013 to June2016. Out of 71 females studied, 45 patients (63.5%) had completed 3 years of follow-up. The data were collected from inpatient and outpatient records. Patients were studied under three groups (A, patients with polycystic ovarian disease (PCOD) symptoms; B, patients with primary infertility; and C, patients who conceived after bariatric surgery that were included in groups A and B).
Results
Out of 45 patients studied, 40 patients underwent laparoscopic sleeve gastrectomy (LSG), four patients underwent laparoscopic Roux-en-Y gastric bypass (RYGB), and one patient underwent laparoscopic adjustable gastric banding (LAGB). The mean BMI of the patients was 43.64 ± 6.8 kg/m2. PCOD symptoms improved symptomatically (p = 0.001) after surgery in the group. Seven (43.75%) primary infertility patients conceived after surgery. Three (42.9%) patients conceived naturally while 4 (57.1%) conceived with ART in group B. Out of total population of 45 in group C, percentages of patients who delivered baby with short gestational age (SGA), low birth weight (LBW), normal vaginal deliveries (NVD), and maternal anemia were 63.15%,47.3%,73.4%, and26.3%, respectively.
Conclusion
Obesity is closely associated with primary infertility and PCOD. Menstrual abnormalities associated with PCOD significantly improve after bariatric surgery with significant improvement in fertility along with maternal outcomes.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The global prevalence of obesity has nearly tripled between 1975 and 2016 [1]. Prevalence of overweight and obesity has increased by many-fold among most Asian countries in the past few decades [2, 3]. Literature has shown 39% of men and 40% of women were overweight while two in every five adults were obese [4]. Eleven percent of men and 15% of women were obese as estimated by the WHO (BMI > 30 kg/m2) [1]. Apart from the pathological and psychosocial outcomes, obesity predisposes metabolic disorders like insulin resistance, type 2 diabetes (T2DM), systemic hypertension (SHT), dyslipidemia, obstructive sleep apnea (OSA), PCOD, and related infertility [5].
In a study done by Leddy MA et al. and Fitzsimons et al., it was shown that maternal obesity increased the risk of preeclampsia, C-section, stillbirth, and congenital anomalies in obese pregnant females [6, 7]. A balanced diet with restricted calories and physical exercise is the key to weight loss and formed the primary treatment for obesity. Bariatric surgery was considered as the option for BMI > 40 or BMI > 35 with comorbidities like T2DM, SHT, dyslipidemia, OSA, and PCOD [8, 9].
Methods
The study was a single institutional, retrospective study. Data of patients who underwent bariatric surgery between June2013 and June 2016 with an age limit of 14 to 30 years were collected from inpatient case sheet and outpatient follow-up. The remaining information was obtained through telephonic conversations. We performed the study in the Department of Obesity and Metabolic Surgery in a tertiary care referral center in India. Results were analyzed under three groups as follows.
Group A—patients who underwent bariatric surgery (BS) for PCOD (married and unmarried)
Group B—patients who underwent BS for primary infertility
Group C—patients who became pregnant after BS (included in groups A and B)
Exclusion Criteria
Patients with primary ovarian insufficiency, endometriosis, secondary infertility, strong family history of infertility, uterine fibroids, and endometrial tuberculosis were excluded from our study.
Definitions
Polycystic Ovarian Disease
Polycystic ovarian disease (PCOD) was defined as a group of symptoms (based on the Rotterdam criteria), which was due to elevated androgen (male hormones) in females [10,11,12].
Rotterdam Criteria
PCOD diagnosis should meet any two of these following criteria: (a) clinical hyperandrogenism (Ferriman–Gallwey score ≥ 8) or biochemical hyperandrogenism (elevated total/free testosterone); (b) oligomenorrhea (< 6–9 menses/year) or oligoovulation; (c) polycystic ovaries on ultrasound (≥ 12 antral follicles in one ovary or ovarian volume ≥ 10 cm2) [13, 14].
Infertility
Infertility was a disease of the reproductive system, which was defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse [15].
Small for Gestational Age
Small for gestational age (SGA) was defined as a weight below ten percentile for gestational age [16, 17].
Terms of Pregnancy
Terms of pregnancy 37–38 weeks are defined as early pregnancy, 39–40 weeks a full-term pregnancy, 41 weeks a late pregnancy, and 42 weeks a post-term pregnancy [18].
Terms of Low Birth Weight
Low birth weight had been defined as first weight recorded within hours of the birth of ≤ 2500 g. Very low birth weight (VLBW) is accepted as < 1500 g, and extremely low birth weight (ELBW) as < 1000 gm [19].
Maternal Anemia
As per the global library of women’s medicine, maternal anemia was defined as hemoglobin level < 11 gm/dl during pregnancy [20].
Statistical Analysis
Data were collected and analyzed. The responses to questions were reported as frequencies or percentages. Statistical analysis was done using SPSS version 20.0 (SPSS Inc., IL, USA). For continuous variables, results were shown as mean ± standard deviation (SD). For continuous variables, paired t test was used, while the chi-square test was done for categorical variables. Significance was considered when the p value was < 0.05.
Results
Seventy-one patients underwent BS in our study. Among them, 45 patients had completed 3 years of regular follow-up. Of the total of 45 patients who underwent bariatric surgical procedures, 40 patients underwent LSG, 4 patients RYGB, and 1 patient LAGB, respectively. Among the 45 patients, 16 married patients had a history of infertility who failed to conceive with assisted reproductive technique (ART) (group B). Twenty-nine patients had symptoms of PCOD (group A) who fulfilled the Rotterdam criteria.
Group A
Twenty-nine patients with PCOD symptoms were included in this group. Mean age of this group was 24.7 ± 10.2 years and mean BMI before surgery was 41.5 ± 6.8 kg/m2. Among the 29 patients, 25, 3, and one patient underwent LSG, RYGB, and LAGB, respectively. They achieved 66.9% ± 24.0% excess weight loss and 76.6% excess BMI loss at the end of 3 years. Improvements in PCOD symptoms are presented in Table 2.
Group B
Sixteen patients with primary infertility were included in this group. The mean BMI before surgery was 48.5 ± 7.9 kg/m2 and mean BMI during conception was significantly reduced to 31.8 ± 6.3 kg/m2 (p < 0.001). Among 16 patients, 7 (43.75%) (p = 0.61) gave live birth after surgery. Out of 7 patients who became pregnant, 3 (42.9%) patients conceived naturally, and 4 (57.1%) patients conceived after ART. All the women conceived in 21.4 ± 2.3 months. The patients in this subgroup achieved 67.4% of excess weight loss (%EWL) and 71.8% of excess BMI loss (%EBMIL) during conception. Nine patients (56.2%) did not conceive after surgery.
Group C
The intent of this group is to analyze the maternal complication for the patients post-BS. Out of 45 patients studied, 19 patients conceived and gave live birth. Twelve (63.15%) patients had an early term (37–38 weeks), and 7 (36.82%) patients had a full-term (39–40 weeks) pregnancy. There were no incidences of post-term pregnancy noted. Nine (47.3%) low birth weight (≤ 2.5 kg) children were born out of 19 patients. Mean body weight of LBW infants was 2.13 ± 0.8 kg. There were no congenital anomalies seen in any of the infants who were with LBW. Fourteen (73.6%) patients had a normal delivery, 5 (26.3%) patients had a cesarean section, while 7 (36.8 %) patients had an incidence of maternal anemia. There was no incidence of gestational diabetes and hypertension (Table 1).
Discussion
Female reproductive health is essential for the development of a healthy nation. The same is affected by medical, psychosocial, and economic factors [21]. These factors could be classified into two major categories—gynecological and obstetrical. Obesity negatively impacts female reproductive health in both manners [22]. Our study aimed to project the effectiveness of bariatric surgery in all aspects of female reproductive health, such as PCOD symptoms, infertility, fetal, and overall maternal health.
PCOD is one of the most common causes of female infertility [23]. The recent prevalence of PCOD in India is 11.9%, as quoted by Choudhary A et al. [24]. Females with PCOD are more prone to develop metabolic syndrome [25]. These patients are at higher risk for infertility [26]. Characteristics which are associated with PCOD are central obesity (CO), higher prevalence of insulin resistance and also higher incidence of metabolic disorders such as T2DM, SHT, and dyslipidemia [27, 28]. Increased visceral fat leading to insulin resistance in patients with PCOD that remains unclear could be a potential mechanism for the same [29]. A study by Sam S et al. shows 40–80% of women suffering from PCOD were obese [30]. The complex nature and pathophysiology of PCOD had been attributed to increased waist circumference, insulin resistance, hypothalamic-pituitary-ovarian axis hormonal imbalance, and the immature follicular generation that resulted in anovulatory cycles [31]. Increased visceral fat was associated with a higher level of inflammatory markers in PCOD [32]. Elevated levels of circulatory insulin reduce the synthesis of sex hormone–binding globulin (SHBG) resulting in increased free testosterone in circulation [33]. Ovaries are highly sensitive to Luteinizing hormone (LH) in PCOD patient that in turn could be a cause for hyperandrogenism [34]. Management of PCOD has been based on symptomology and weight loss by diet, and lifestyle changes are the primary steps of PCOD treatment. Improvement in PCOD symptoms with as little as 5% of excess weight loss has been shown in a study by Badawy et al. [35]. In our study, patients achieved 66.9% EWL and 76.6% EBMI lost to follow-up of 1–3 years. We observed that most of PCOD symptoms improved significantly after BS, as shown in Table 2. Similar results were found in a meta-analysis by Skubleny et al. and also in a prospective study by Escobar et al. as follow (p < 0.001 and p < 0.005), respectively [36, 37].
Infertility is a significant concern for many, which is now increasing in the current era. Obesity negatively impacts female infertility. Indians have reported a fertility rate of 2.303 children per women [38]. Various ART methods are available for treating infertility, and only 50–60% of couples receiving ART’s achieve pregnancy, as depicted in a study by Rich Edwards et al. [39]. Obesity in the reproductive age group ranged between 24.2 and 28.3% according to study by Khan R et al. [40]. Most infertile women are overweight and obese in the category. There are only 5% chances of giving live birth in obese females as showed by Rich Edwards et al. [39]. Grodstein et al. found that anovulatory infertility was higher in the overweight and obese patients [41]. Obesity is contributing to increased conversion of androgen to estrogens in adipose tissue, which causes decreased GnRH by negative feedback. Therefore, affected hypothalamic-pituitary-gonadal-axis causes an irregular menstrual cycle [42,43,44,45]. According to the NICE guidelines, there was an improvement in fertility rate when the bodyweight reduced by 10% [46]. Considering the above perspectives and the close relationship between obesity and fertility trends, BS could play a significant role in the improvement of women’s reproductive health. A study published by Merhi zo et al. showed that there could be a partial or complete alteration of reproductive hormone profile post BS [47].
In our study, we observed a fertility rate of 43.75% after BS. It was also observed that there was a significant reduction of mean BMI before and after BS, from 48.5 ± 7.9 kg/m2 to 31.8 ± 6.3 kg/m2 (p < 0.001). Concordant results were shown in the studies by Marceau et al. and Deitel et al. with fertility rates improving to 46.9% and 88.9%, respectively, after BS [48, 49]. With the above results, it becomes imperative to conclude that BS could provide a significant positive impact on the fertility rate in the obese subset of the population.
In post BS, we observed that there was a significant incidence of early term pregnancy of 63.2% (p = 0.005) while low birth weight was 47.4% (p = 0.819) (Table 3). Studies by Wax et al., Patel et al., and Richard et al. showed an incidence of SGA post-bariatric surgery as 26.3%, 26.9%, and 12.3%, respectively [50,51,52]. Equivalent results were found in studies by Wax et al. and Chevrot et al., where % of LBW post-bariatric surgery was 7.7% and 9–29% [50, 53]. It was observed that we had a higher incidence of SGA and LBW in our study when compared with these studies. The possible explanation to the above results could be related to the Indian cultural context where most people consume low protein and overall a poor nutritious intake pattern.
Developing nations like India bear a double-edged sword with undernutrition on one side and obesity on the other. The study by Laura et al. showed that maternal obesity significantly increased the risk of fetal macrosomia [54]. This study also showed that pre-pregnancy weight reduction could help to avert fetal macrosomia. Bariatric surgery could reduce the occurrence of fetal macrosomia, but at the same time, it also increases the possibilities of LBW simultaneously. Hence, there should be a necessity of bariatric-obstetric team approach while handling post-bariatric pregnancies and to obtain optimum outcomes.
It is well proven that maternal obesity has been strongly associated with maternal and fetal morbidity during the time of delivery [55, 56]. Obesity causes an increased risk of C-section, as shown in a study by Kaplan et al. [57]. It has been found out that leptin and cholesterol which are higher in obese patients causing poor uterine contractility due to less calcium ion (Ca2+) influx in the myometrium, which seems to be a pathophysiology factor for patients landing up in C-section in obese patients [58,59,60]. Prevalence of C-section in India was estimated to be around 17.2% between 2015 and 2016 [61, 62]. We have observed an increasing trend since then. In a study by Berendzen JA et al., there was an increased prevalence of C-section in the obese population and which found to be 39–59% [63].
In our study, we found a statistical increased in rates of normal vaginal delivery rate of 73.7% (p = 0.019) when compared with a C-section rate of 26.3% post-bariatric surgery (Table 3). A study by Lapolla et al. showed a reduction of C-sections to 45.9% after bariatric surgery compared with 65.8% C-section in obese pregnancies which did not undergo any treatment for weight loss [64]. Our study finds coherence and also finds its support from studies done by Wax JR et al., Kjaer MM et al., and Josefsson A et al., where they found a significant reduction of C-section (18.3–60 %) following bariatric surgery when compared with patients who had undergone any treatment for obesity [50, 65, 66].
Anemia during the natal period is one of the most important factors associated with several maternal and fetal complications. In a study by Munasinghe et al., the authors quoted that the causes of maternal anemia could be due to deficiencies in the nutritional components like iron, folate, vitamin B12 and vitamin A [67]. Anemia has also been associated with increased risk of intrauterine growth restriction (IUGR), premature deliveries, LBW, maternal mortality, and stillbirths. Anemia is found to decrease the women’s reserve to tolerate bleeding either during or after childbirth, hence increasing the propensity to develop infections in the natal and post-natal period. India has been found to have a prevalence of maternal anemia of 65–75% as shown in a study by Vanamala et al. and Kalaivani K et al. [68, 69]. We found that the incidence of maternal anemia in post-BS patients was 36.8% (p = 0.251) (Table 3). Optimization of anemia if diagnosed pre-operatively was done by iron and folic acid supplements. As per our institutional protocol and recommendations, we gave supplements of vitamin B12, calcium, and multivitamins for a minimum period of 6 months post-surgery. During the subsequent follow-ups, if the patient developed anemia, iron and folic acid supplements were given after investigating the cause for the same. A study by Victoria et al. has also shown a higher risk of maternal anemia in mothers with a prior history of BS [70]. A significant (p = 0.002) rate of maternal anemia was seen in a study by Galazis N et al. [71]. We did not observe any adverse effects such as congenital malformation like fetal macrosomia in our patients’ post-bariatric surgery. Post-bariatric surgery maternal anemia needs to be monitored properly, and iron replacement to be done at the earliest (Figure 1).
Postponing pregnancy for 1–2 years after bariatric surgery has been suggested [72,73]. This timeframe could be helpful to decrease hormonal instability in mothers, which may improve the necessary healthy nutritional environment to the fetal growth as emphasized in studies by Kominiarek MA et al., Leung TY et al., and Mansourian AR et al. [74,75,76]. Careful coordination with the bariatric surgeon and obstetrician is needed to avoid inadvertent complication to the mother and the baby.
Limitations
Our study was a single institutional, retrospective study. PCOD improvement was subjectively estimated by symptomatic relief; however, biochemical or ultrasound imaging was not used in the post-operative period. Gestational diabetes, inadequate lactation, maternal nutritional supplementation, nutritional deficiency, Apgar score in newborn, and post-delivery weight gain were not analyzed in our study. We also could not study pre-operative psychological assessment and also post-bariatric quality of life (QOL) assessment.
Conclusion
BS could provide significant improvements in menstrual abnormalities, primary infertility, and also maternal outcomes in addition to substantial weight loss. Although ART techniques may be necessary for many, their results enhance significantly post-bariatric surgery. Reasonable care from the first trimester is essential to tackle the higher incidence of SGA birth, LBW, and maternal anemia post weight loss surgery. Adequate follow-ups could improve maternal and post-natal infant outcomes with proper coordination between obstetric and the bariatric team.
References
WHO. Obesity and overweight. [cited 2019 Jun 14]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
Yoon K-H, Lee J-H, Kim J-W, Cho JH, Choi Y-H, Ko S-H, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006 [cited 2019 Aug 2];368(9548):1681–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17098087.
Ramachandran A, Snehalatha C. Rising burden of obesity in Asia. J Obes. 2010 [cited 2019 Aug 2];2010. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20871654.
Helble M, Sato A. Wealthy but unhealthy: overweight and obesity in Asia and the Pacific: trends, costs, and policies for better health. 2030 [cited 2019 Jul 30]. Available from: www.adbi.org.
Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005 [cited 2019 Jul 30];352(12):1223–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15788499.
Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynecol. 2008 [cited 2019 Jun 14];1(4):170–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19173021.
Fitzsimons KJ, Modder J, Greer IA. Obesity in pregnancy: risks and management. Obstet Med. 2009 [cited 2019 Jun 14];2(2):52–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27582812.
Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992 [cited 2019 Jul 30];55(2):615S-619S. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1733140.
Sjöholm K, Anveden A, Peltonen M, Jacobson P, Romeo S, Svensson P-A, et al. Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study. Diabetes Care. 2013 [cited 2019 Jul 30];36(5):1335–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23359358.
About polycystic ovary syndrome (PCOS) | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development. [cited 2019 Jun 14]. Available from: https://www.nichd.nih.gov/health/topics/pcos/conditioninfo.
Polycystic ovary syndrome (PCOS) fact sheet | womenshealth.gov. [cited 2019 Jun 14]. Available from: https://web.archive.org/web/20160812093306/http://womenshealth.gov/publications/our-publications/fact-sheet/polycystic-ovary-syndrome.html.
Stankiewicz M, Norman R. Diagnosis and management of polycystic ovary syndrome. Drugs. 2006 [cited 2019 Jun 14];66(7):903–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16740005.
Wang R, Mol BWJ. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod. 2017 [cited 2019 Jun 19];32(2):261–4. Available from: https://academic.oup.com/humrep/article-lookup/doi/10.1093/humrep/dew287.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 [cited 2019 Aug 2];81(1):19–25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14711538.
Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009∗. Fertil Steril. 2009 [cited 2019 Jul 23];92(5):1520–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19828144.
Schlaudecker EP, Munoz FM, Bardají A, Boghossian NS, Khalil A, Mousa H, et al. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data. Vaccine. 2017 [cited 2019 Jul 27];35(48 Pt A):6518–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29150057.
WHO | Physical status: the use and interpretation of anthropometry. WHO. 2013 [cited 2019 Jul 27]; Available from: https://www.who.int/childgrowth/publications/physical_status/en/.
American College of Obstetricians and Gynecologists. ACOG committee opinion. American College of Obstetricians and Gynecologists; [cited 2019 Jul 27]. Available from: https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Definition-of-Term-Pregnancy?IsMobileSet = false.
Cutland CL, Lackritz EM, Mallett-Moore T, Bardají A, Chandrasekaran R, Lahariya C, et al. Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2017 [cited 2019 Jul 17];35(48 Pt A):6492–500. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29150054.
Sciarra JJ, Holzgreve W, Downes E. The global library of women’s medicine. Sapiens Global Library; [cited 2019 Jul 27]. Available from: https://www.glowm.com/Critical_current_issue/page/25.
Causes of female infertility - UpToDate. [cited 2019 Jul 20]. Available from: https://www.uptodate.com/contents/causes-of-female-infertility#H1.
Balen AH, Anderson RA, Policy & Practice Committee of the BFS. Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Hum Fertil. 2007 [cited 2019 Jul 19];10(4):195–206. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18049955.
Brugo-Olmedo S, Chillik C, Kopelman S. Definition and causes of infertility. Vol. 2, Reproductive BioMedicine Online. [cited 2019 Jul 20]. Available from: https://www.rbmojournal.com/article/S1472-6483(10)62193-1/pdf.
Choudhary A, Jain S, Chaudhari P. Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence? Int J Reprod Contraception, Obstet Gynecol. 2017 [cited 2019 Jun 14];6(11):4971. Available from: http://www.ijrcog.org/index.php/ijrcog/article/view/3590.
Homburg R. Polycystic ovary syndrome--from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod. 1996 [cited 2019 Aug 2];11(1):29–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8671153.
Chandrasekaran S, Sagili H. Metabolic syndrome in women with polycystic ovary syndrome. Obstet Gynaecol. 2018 [cited 2019 Aug 2];20(4):245–52. Available from: http://doi.wiley.com/10.1111/tog.12519.
Li Y, Lin H, Pan P, Yang D, Zhang Q. Impact of central obesity on women with polycystic ovary syndrome undergoing in vitro fertilization. Biores Open Access. 2018 [cited 2019 Jul 20];7(1):116–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30083428.
Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989 [cited 2019 Jul 23];38(9):1165–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2670645.
Lord J, Thomas R, Fox B, Acharya U, Wilkin T. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG An Int J Obstet Gynaecol. 2006 [cited 2019 Jul 23];113(10):1203–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16753044.
Sam S. Obesity and polycystic ovary syndrome. Obes Manag. 2007 [cited 2019 Jun 19];3(2):69–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20436797.
Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Pract Res Clin Obstet Gynaecol. 2004 [cited 2019 Aug 2];18(5):685–706. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15380141.
Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril. 2006 May [cited 2019 Jul 23];85(5):1319–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16647374.
Haffner SM. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm Res. 1996 [cited 2019 Aug 7];45(3–5):233–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8964590.
Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 [cited 2019 Jul 23];37(5):467–520. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27459230.
Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Womens Health. 2011 [cited 2019 Jul 23];3:25–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21339935.
Escobar-Morreale HF, Botella-Carretero JI, Álvarez-Blasco F, Sancho J, San Millán JL. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab. 2005 [cited 2019 Jul 23];90(12):6364–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16189250.
Skubleny D, Switzer NJ, Gill RS, Dykstra M, Shi X, Sagle MA, et al. The impact of bariatric surgery on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Surg. 2016 [cited 2019 Jul 23];26(1):169–76. Available from: http://springerlink.bibliotecabuap.elogim.com/10.1007/s11695-015-1902-5.
Fertility Rate By Country 2019. [cited 2019 Jun 14]. Available from: http://worldpopulationreview.com/countries/total-fertility-rate/.
Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994 [cited 2019 Jun 14];171(1):171–7. Available from: https://linkinghub.elsevier.com/retrieve/pii/0002937894904650.
Khan R, Dawlatly B, Chappatte O. Pregnancy outcome following bariatric surgery. Obstet Gynaecol. 2013 [cited 2019 Jun 14];15(1):37–43. Available from: http://doi.wiley.com/10.1111/j.1744-4667.2012.00142.x.
Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology. 1994 [cited 2019 Aug 6];5(2):247–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8173001.
Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab. 1996 [cited 2019 Aug 6];81(1):302–9. Available from: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jcem.81.1.8550768.
Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod. 1994 [cited 2019 Aug 6];9(2):188–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8027271.
Pasquali R, Pelusi C, Genghini S, Cacciari M, Gambineri A. Obesity and reproductive disorders in women. Hum Reprod Update. 2003 [cited 2019 Aug 6];9(4):359–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12926529.
Bellver J, Melo MAB, Bosch E, Serra V, Remohí J, Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril. 2007 [cited 2019 Aug 6];88(2):446–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17418840.
Overview | Weight management before, during and after pregnancy | Guidance | NICE. [cited 2019 Jun 14]; Available from: https://www.nice.org.uk/guidance/ph 27.
Merhi ZO. Impact of bariatric surgery on female reproduction. Fertil Steril. 2009 [cited 2019 Jul 19];92(5):1501–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19665703.
Marceau P, Kaufman D, Biron S, Hould F-S, Lebel S, Marceau S, et al. Outcome of pregnancies after biliopancreatic diversion. Obes Surg. 2004 [cited 2019 Jul 24];14(3):318–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15072650.
Deitel M, Stone E, Kassam HA, Wilk EJ, Sutherland DJ. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr. 1988 [cited 2019 Jul 24];7(2):147–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3361039.
Wax JR, Cartin A, Wolff R, Lepich S, Pinette MG, Blackstone J. Pregnancy following gastric bypass for morbid obesity: effect of surgery-to-conception interval on maternal and neonatal outcomes. Obes Surg. 2008 [cited 2019 Jun 17];18(12):1517–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18685903.
Patel JA, Patel NA, Thomas RL, Nelms JK, Colella JJ. Pregnancy outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008 [cited 2019 Jul 25];4(1):39–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18201669.
Richards DS, Miller DK, Goodman GN. Pregnancy after gastric bypass for morbid obesity. J Reprod Med. 1987 [cited 2019 Jul 25];32(3):172–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3572896.
Chevrot A, Kayem G, Coupaye M, Lesage N, Msika S, Mandelbrot L. Impact of bariatric surgery on fetal growth restriction: experience of a perinatal and bariatric surgery center. Am J Obstet Gynecol. 2016 [cited 2019 Jun 17];214(5):655.e1-655.e7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26627725.
Gaudet L, Ferraro ZM, Wen SW, Walker M. Maternal obesity and occurrence of fetal macrosomia: a systematic review and meta-analysis. Biomed Res Int. 2014 [cited 2019 Jul 25];2014:640291. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25544943.
Baron CM, Girling LG, Mathieson AL, Menticoglou SM, Seshia MM, Cheang MS, et al. Obstetrical and neonatal outcomes in obese parturients. J Matern Neonatal Med. 2010 [cited 2019 Jul 25];23(8):906–13. Available from: http://www.tandfonline.com/doi/full/10.3109/14767050903338472.
Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. 2004 [cited 2019 Jul 25]; Available from: https://pdfs.semanticscholar.org/d59a/8ec46fd4f261fd2177141a2aaf62d1b8eafe.pdf.
Kaplan-Sturk R, Åkerud H, Volgsten H, Hellström-Westas L, Wiberg-Itzel E. Outcome of deliveries in healthy but obese women: obesity and delivery outcome. BMC Res Notes. 2013 [cited 2019 Jul 25];6:50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23388378.
Zhang J, Bricker L, Wray S, Quenby S. Poor uterine contractility in obese women. BJOG An Int J Obstet Gynaecol. 2007 [cited 2019 Aug 7];114(3):343–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17261121.
Wuntakal R, Kaler M, Hollingworth T. Women with high BMI: should they be managed differently due to antagonising action of leptin in labour? Med Hypotheses. 2013 Jun [cited 2019 Aug 7];80(6):767–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23570649.
Jie Zhang, Kendrick A, Quenby S, Wray S. Contractility and calcium signaling of human myometrium are profoundly affected by cholesterol manipulation: implications for labor? Reprod Sci. 2007 [cited 2019 Aug 7];14(5):456–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17913965.
The National Family Health Survey (NFHS-3) - India - Health education to villages. [cited 2019 Jun 17]. Available from: http://hetv.org/india/nfhs/.
National Family Health Survey. [cited 2019 Jun 17]. Available from: http://rchiips.org/nfhs/factsheet_nfhs-4.shtml.
Berendzen JA, Howard BC. Association between cesarean delivery rate and body mass index. Tenn Med. 2013 [cited 2019 Jun 17];106(1):35–7, 42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23477241.
Lapolla A, Marangon M, Dalfrà MG, Segato G, De Luca M, Fedele D, et al. Pregnancy outcome in morbidly obese women before and after laparoscopic gastric banding. Obes Surg. 2010 [cited 2019 Jul 25];20(9):1251–7. Available from: http://springerlink.bibliotecabuap.elogim.com/10.1007/s11695-010-0199-7.
Kjær MM, Lauenborg J, Breum BM, Nilas L. The risk of adverse pregnancy outcome after bariatric surgery: a nationwide register-based matched cohort study. Am J Obstet Gynecol. 2013 [cited 2019 Jun 17];208(6):464.e1-464.e5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S000293781300241X.
Josefsson A, Blomberg M, Bladh M, Frederiksen SG, Sydsjö G. Bariatric surgery in a national cohort of women: sociodemographics and obstetric outcomes. Am J Obstet Gynecol. 2011 [cited 2019 Jun 17];205(3):206.e1-206.e8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002937811003632.
Munasinghe S, van den Broek N. Anaemia in pregnancy in Malawi- a review. Malawi Med J. 2006 [cited 2019 Aug 6];18(4):160–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27529009.
Vanamala VG, Rachel A, Pakyanadhan S. Incidence and outcome of anemia in pregnant women: a study in a tertiary care centre. Int J Reprod Contraception, Obstet Gynecol. 2018 [cited 2019 Jun 17];7(2):462. Available from: http://www.ijrcog.org/index.php/ijrcog/article/view/4332.
Kalaivani K. Prevalence & consequences of anaemia in pregnancy. Indian J Med Res. 2009 [cited 2019 Jun 17];130(5):627–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20090119.
Belogolovkin V, Salihu HM, Weldeselasse H, Biroscak BJ, August EM, Mbah AK, et al. Impact of prior bariatric surgery on maternal and fetal outcomes among obese and non-obese mothers. Arch Gynecol Obstet. 2012 [cited 2019 Jul 27];285(5):1211–8. Available from: http://springerlink.bibliotecabuap.elogim.com/10.1007/s00404-011-2134-0.
Galazis N, Docheva N, Simillis C, Nicolaides KH. Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014 [cited 2019 Jun 17];181:45–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25126981.
Iavazzo C, Ntziora F, Rousos I, Paschalinopoulos D. Complications in pregnancy after bariatric surgery. Arch Gynecol Obstet. 2010 [cited 2019 Aug 7];282(2):225–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20039048.
Karmon A, Sheiner E. Timing of gestation after bariatric surgery: should women delay pregnancy for at least 1 postoperative year? Am J Perinatol. 2008 [cited 2019 Aug 7];25(6):331–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18493884.
Mansourian AR. Thyroid function tests during first-trimester of pregnancy: a review of literature. Pakistan J Biol Sci. 2010 [cited 2019 Aug 7];13(14):664–73. Available from: http://www.scialert.net/abstract/?doi = pjbs.2010.664.673.
Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Lau TK. First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol. 2006 [cited 2019 Aug 7];27(2):156–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16435317.
Kominiarek MA. Preparing for and managing a pregnancy after bariatric surgery. Semin Perinatol. 2011 [cited 2019 Aug 7];35(6):356–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22108087.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Consent
Consent had been attained from the patients before the surgery
Ethical Clearance
The institutional ethical committee had approved the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Christinajoice, S., Misra, S., Bhattacharya, S. et al. Impact of Bariatric Surgery on Female Reproductive Health and Maternal Outcomes. OBES SURG 30, 383–390 (2020). https://doi.org/10.1007/s11695-019-04245-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-019-04245-0